Venetoclax combination with Cladribine, idarubicin, Cytarabine for relapsed T-Cell acute lymphoblastic leukemia/lymphoblastic lymphoma treatment: A case report and literature review

Venetoclax combination with Cladribine, idarubicin, Cytarabine for relapsed T-Cell acute lymphoblastic leukemia/lymphoblastic lymphoma treatment: A case report and literature review

Acute lymphoblastic leukemia (ALL) represents only 20 % of adult acute leukemias, while Lymphoblastic lymphoma is even rarer, accounting for 2 % of adult non-Hodgkin lymphomas. T-acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL) are neoplasms characterized by the presence of...

Full description

Saved in:
Bibliographic Details
Main Authors: Alaa Eldein Yahia, Ibrahim Motabi, Abdullah A. Alsakkaf, Kamal Alzahrani, Laila M. Alsuhaibani, Bilal Albtoosh, Abdullah Khaled AlBathi, Abdullah M. Alrajhi
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Leukemia Research Reports
Subjects:
Venetoclax
Cladribine
Idarubicin
Cytarabine
T-cell acute lymphoblastic lymphoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048925000081
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2213048925000081

Similar Items